CAS NO: | 86879-39-2 |
包装 | 价格(元) |
500ug | 电议 |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
Physical Appearance | A crystalline solid |
Storage | Store at -20°C |
M.Wt | 240.25 |
Cas No. | 86879-39-2 |
Formula | C12H16O5 |
Solubility | insoluble in H2O; ≥48.4 mg/mL in EtOH; ≥49.4 mg/mL in DMSO |
Chemical Name | 2-(2-carboxyethyl)-4-methyl-5-propylfuran-3-carboxylic acid |
Canonical SMILES | CCCC1=C(C)C(C(O)=O)=C(CCC(O)=O)O1 |
运输条件 | 蓝冰运输或根据您的需求运输。 |
一般建议 | 为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同厂家不同批次产品溶解度各有差异,仅做参考。若实验所需浓度过大至产品溶解极限,请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存,请尽快用完。 |
CMPF is an endogenous metabolite of furan fatty acids. CMPF is highly bound to albumin. Its main role is to inhibit cell transport and subsequent deiodination of thyroxine (T4)[1].
CMPF can effectively replace the competitive T4 binding molecules in albumin and play a role by indirectly binding albumin. And CMPF can inhibit the binding of T4 and albumin by increasing the serum concentration of competitive binding molecules such as oleic acid[2].
References:
[1]. Lim C, Bernard B F, De Jong M, et al. A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia. The Journal of Clinical Endocrinology and Metabolism, 1993, 76(2): 318-324.
[2]. Lim C F, Stockigt J R, Curtis A J, et al. A naturally occuring furan fatty acid enhances drug inhibition of thyroxine binding in serum. Metabolism, 1993, 42(11): 1468-1474.